IRIS UniCatt

De Marinis Grasso, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.550
EU - Europa 5.665
AS - Asia 5.228
SA - Sud America 1.158
AF - Africa 140
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.352
SG - Singapore 2.291
DE - Germania 2.200
CN - Cina 1.280
BR - Brasile 931
SE - Svezia 821
VN - Vietnam 609
UA - Ucraina 558
IT - Italia 510
FR - Francia 451
GB - Regno Unito 272
IE - Irlanda 227
IN - India 218
FI - Finlandia 181
ID - Indonesia 159
JP - Giappone 138
RU - Federazione Russa 133
HK - Hong Kong 110
CA - Canada 100
AR - Argentina 84
BD - Bangladesh 72
TR - Turchia 65
IQ - Iraq 55
MX - Messico 54
NL - Olanda 49
PL - Polonia 48
BE - Belgio 46
EC - Ecuador 38
AT - Austria 35
ES - Italia 32
PK - Pakistan 31
ZA - Sudafrica 31
MA - Marocco 25
VE - Venezuela 24
SA - Arabia Saudita 23
CL - Cile 22
CO - Colombia 20
UZ - Uzbekistan 20
KR - Corea 17
AE - Emirati Arabi Uniti 15
EG - Egitto 14
PE - Perù 14
KZ - Kazakistan 13
PY - Paraguay 13
RO - Romania 13
CH - Svizzera 12
IR - Iran 12
JO - Giordania 12
SN - Senegal 11
TN - Tunisia 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
MY - Malesia 10
AL - Albania 9
CI - Costa d'Avorio 9
KE - Kenya 9
LT - Lituania 9
PT - Portogallo 9
AU - Australia 8
CR - Costa Rica 8
JM - Giamaica 8
PH - Filippine 8
DZ - Algeria 7
ET - Etiopia 7
IL - Israele 7
LB - Libano 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
LK - Sri Lanka 6
MD - Moldavia 6
NP - Nepal 6
QA - Qatar 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
BG - Bulgaria 4
GE - Georgia 4
HN - Honduras 4
HU - Ungheria 4
NG - Nigeria 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
DK - Danimarca 3
KG - Kirghizistan 3
LV - Lettonia 3
RS - Serbia 3
AO - Angola 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
AD - Andorra 1
Totale 18.730
Salva come PNG Salva come JPEG
Città #
Singapore 1.212
Chandler 847
Ashburn 708
San Jose 669
Beijing 230
Jacksonville 220
Dublin 218
Ho Chi Minh City 216
San Mateo 214
Ann Arbor 206
New York 194
Los Angeles 164
Nanjing 149
Hanoi 140
Jakarta 138
Lauterbourg 132
Wilmington 126
Hefei 124
Tokyo 112
Boston 109
Rome 105
Nürnberg 98
Hong Kong 96
Munich 94
The Dalles 94
Houston 90
Marseille 90
São Paulo 89
Moscow 88
Milan 86
Dearborn 79
Frankfurt am Main 79
Chicago 71
Woodbridge 69
Dallas 66
Princeton 65
Helsinki 57
Cattolica 52
Lawrence 52
Seattle 52
Redwood City 51
Nanchang 50
Kent 49
Bremen 48
Santa Clara 48
St Louis 46
Brussels 44
Mountain View 43
Zhengzhou 43
University Park 40
Montreal 38
Boardman 36
Hangzhou 35
Izmir 35
Detroit 34
Rio de Janeiro 34
Shanghai 34
Buffalo 33
Delhi 33
Da Nang 32
Fairfield 31
Warsaw 30
Denver 29
Orem 29
Brooklyn 28
Norwalk 28
Shenyang 28
Lancaster 27
Paris 27
Turku 27
Fremont 26
London 25
Nuremberg 24
Changsha 23
Guangzhou 22
Haiphong 22
Leawood 22
Tianjin 22
Belo Horizonte 21
Kunming 21
Chennai 20
Hebei 20
Atlanta 19
Baghdad 19
Düsseldorf 19
Redmond 19
Jiaxing 18
Amsterdam 17
Poplar 17
Stockholm 17
Tashkent 17
Cambridge 16
Mumbai 16
Porto Alegre 16
Bexley 15
Dhaka 15
Johannesburg 15
Quito 15
Seoul 15
Vienna 15
Totale 9.358
Salva come PNG Salva come JPEG
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 306
The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel 292
Growth hormone in inflammatory bowel disease 260
Evaluation of antioxidants systems in pituitary-adrenal axis diseases. 249
Double pituitary adenomas 237
Seminal antioxidant capacity in pre- and postoperative varicocele 232
Predictors of morbidity and mortality in acromegaly, an Italian survey. 232
Evaluation of Antioxidant systems (Coenzyme Q10 and total antioxidant capacity) in morbidy obesity before and after biliopancreatic diversion 216
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 214
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 210
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 199
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 199
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 198
Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. 196
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 196
Male fertility and reduction in semen parameters: A single tertiary-care center experience 187
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 185
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography 185
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 183
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. 180
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 178
Primary hyperparathyroidism. Our experience 175
[Immunogenetic and functional study of first-degree relatives of patients with type I diabetes mellitus for identifying prediabetic subjects] 174
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 173
Isolated growth hormone deficiency: clinical entity? 167
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 166
Pancreatic metastases from a bronchopulmonary carcinoid diagnosed by endoscopic ultrasonography-guided fine-needle tissue acquisition 165
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 161
Xanthogranuloma of the sellar region: A rare tumor. Case illustration and literature review 160
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 159
[Coexistence of hyperthyroidism and thyroid carcinoma. Description of a clinical case] 159
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 159
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. 159
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 158
Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade 156
Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. 155
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 152
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 151
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 149
Proteomic approach in the identification of fertility pattern in seminal plasma of fertile men 149
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 149
Effects of Testosterone on antioxidant systems in male secondary hypogonadism. 147
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 146
Hypothalamitis: a diagnostic and therapeutic challenge 145
Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity 144
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 142
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin 142
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 142
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 141
GH receptor isoforms and skeletal fragility in acromegaly 140
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 140
Fertility and hypopituitarism 139
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 136
Plasma prolactin response to gonadotropin-releasing hormone during benzodiazepine treatment 133
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 133
Increased total antioxidant capacity in seminal plasma of varicocele patients: a multivariate analysis 132
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure 132
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 132
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 131
ACTH-dependent Cushing syndrome: The potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy 130
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 129
Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle 128
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 127
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 126
Endocrine evaluation of patients with benign lumps of the breast 125
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 124
Prevalence of vertebral fractures in men with acromegaly 124
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 124
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 123
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 121
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 121
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 120
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 116
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 116
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 116
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 115
Reciprocal regulation of microrna-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions 115
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 115
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 113
Empty sella syndrome: Multiple endocrine disorders. 113
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 112
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 112
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. 111
Effects of high-dose octreotide lar on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy 110
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 109
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: A multicenter study 108
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 106
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 105
Vertebral fractures in patients with acromegaly: a 3-year prospective study 105
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 105
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 104
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 104
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 104
Endocrine evaluation of patients with benign lumps of the breast 103
Understanding the effect of acromegaly on the human skeleton. 103
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 103
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 102
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 102
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 102
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 100
Totale 14.878
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.263
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 0 0 0 0 106 157 12
2021/20221.163 60 96 20 79 112 45 26 175 50 66 183 251
2022/20232.397 302 346 194 337 172 283 135 183 266 42 77 60
2023/20241.052 61 319 21 43 51 163 37 19 28 34 118 158
2024/20252.512 63 63 170 81 173 85 28 118 412 221 498 600
2025/20267.017 1.046 268 516 943 1.166 393 1.280 408 439 558 0 0
Totale 19.031